Latest (page 4)

Notable MedicineINT Nature Medicine

Broadly neutralizing antibodies in adult males living with HIV undergoing analytical treatment interruption: secondary and exploratory outcomes of the phase II randomized controlled RIO trial

Nature Medicine, Published online: 15 September 2026; doi:10.1038/s41591-026-04644-8 In the phase 2 RIO trial, there was delayed viral rebound and resistance to broadly neutralizing antibodies 3BNC117-LS and 10-1074-LS in adult males living with…

Read at nature.com ↗Why it matters